Email Updates

Search form

You are here

AVAC's Blog: P-Values

  • AVAC.org and PrEPWatch.org have several new resources and updates. We've rounded up a few select resources. Take a look!

    February 27, 2019
    General, Microbicides, PrEP
    AVAC
  • Incorporating stakeholder engagement early and deeply in the development of a clinical trial for HIV prevention research is for us a clarion call. Including a diverse cross-section of expertise and perspectives at the outset, especially of those who may rely on these strategies to prevent HIV, helps research stay on track to eventually deliver options people will trust and use.

    February 21, 2019
    Jeanne Baron
    Manju Chatani-Gada
  • AVAC wants to hear from you! We launched our podcast, Px Pulse, in late 2017 and since then we have produced 15 episodes bringing you interviews, first-person reflections and rich discussions covering issues facing HIV prevention research and advocacy. Now it’s time for us to take stock and learn more about what you want from Px Pulse and how to deliver it.

    February 19, 2019
    General
    AVAC
  • AVAC is delighted to announce the 2019 AVAC Advocacy Fellows – the 10th class of the Fellows Program! AVAC’s Advocacy Fellows Program was launched in 2009 to expand the capacity of advocates and organizations to monitor, support and help shape biomedical HIV prevention research and implementation in countries where research is ongoing and/or new interventions are being rolled out.

    February 14, 2019
    General
    AVAC
  • In a special issue of Current Opinion in HIV and AIDS, published in January 2019, AVAC staff members Emily Bass, Laura Fitch, Anabel Gomez and Maureen Luba Milambe joined collaborators who work in advocacy and human-centered design to co-author two important articles.

    February 14, 2019
    Jeanne Baron
  • Happy New Year! We hope that you started your year refreshed for important work ahead–and to help get you started, we’ve rounded up a few select resources from AVAC.org that we hope you’ll consider as you set your agenda for 2019. We think these cross-cutting and thought-provoking tools help to frame the most pressing issues facing HIV prevention in the year ahead.

    January 17, 2019
    General, Microbicides, PrEP
    AVAC
  • Is HIV prevention research seeing its last placebo-controlled efficacy trials? Will the field have to radically reimagine how to answer efficacy questions?

    January 10, 2019
    General
    Stacey Hannah
    Ruth Assefa
  • As 2018 comes to an end, AVAC extends gratitude to all HIV prevention advocates—those we work with, those whose names we do not know—for the hope and fierce commitment that you bring to the work every day.

    December 21, 2018
    General
    AVAC
  • In this episode of Px Pulse, we consider how future HIV prevention trials will need to be designed as HIV prevention evolves... and how to strengthen community engagement along with it. At the heart of the matter is that clinical trials for HIV prevention are set to get bigger and more complex, in response to advances in HIV prevention, such as PrEP.

    December 18, 2018
    AVAC
  • As 2018 winds down, we’re struck by the many moments, and movements, in the past year that have depended on listening, without bias and also without loss of conviction. In that spirit, our year-end edition of Px Wire offers 10 questions for activists to pose, with curiosity and conviction, in 2019. What answers do you want, what do you hear, what needs to happen next?

    December 14, 2018
    AVAC

Pages